ENRIQUE HERRERA ACOSTA – ESTUDIO OBSERVACIONAL CON MEDICAMENTO – ALMIRALL S.A.
A multicenter, Prospective, observational study measuring tildrakizumab benefit in Achieving Therapeutic goals in patients with moderate-to-severe plaque psoriasis and inadequate response to previous biologic treatments in clinical practice in Spain.
por prodriguez | Jul 3, 2024 | Ensayos Clínicos, Ensayos Clínicos - B-10 | 0 Comentarios